Language
Branch
Start Your Career
Industry

Biotech Consulting: From cell culture to commercial production.

Biotechnology companies face unique challenges: complex manufacturing processes for biologics, strict GMP requirements for ATMPs, and the pressure to bring innovative therapies to commercial production quickly. ENTOURAGE supports biotech companies from process development through to regulatory approval.

Biotechnology Laboratories and Biopharmaceutical Manufacturing: Consulting for Biotech Companies
+500

Successful biotech and biopharmaceutical projects worldwide
100%

's Audit Success Rate for FDA and EMA Inspections
Top 10
Leading biotech companies
trust our expertise
What is Biotech Consulting?
Biotech consulting involves providing specialized advice to biotechnology companies on the development, approval, and production of biologic drugs. Key areas of focus include process development and scale-up of biologics, CMC documentation, GMP compliance for bioprocessing, ATMP regulations, and clinical development strategies. Consultants assist with technology transfer from the laboratory to commercial manufacturing.

What challenges will shape the biotechnology industry in 2026?

Biotech companies operate in a highly regulated environment that is becoming increasingly complex. The key operational bottlenecks are:

  • The scale-up of biologics from the laboratory scale to GMP-compliant commercial production often fails due to inadequate process characterization
  • ATMP (Advanced Therapy Medicinal Products) regulations require specialized expertise in cell and gene therapies, which is rarely available in-house
  • CMC documentation for biologics and biosimilars is becoming increasingly complex – the EMA and FDA require comprehensive comparability studies
  • Single-use technologies and continuous manufacturing are fundamentally transforming production infrastructure
  • A shortage of specialized bioprocess engineers, cell biologists, and regulatory experts for biologics is slowing down development programs
  • Cold-chain logistics and GDP compliance for temperature-sensitive biologics and mRNA-based therapeutics are becoming a core operational competency
"The key to success in biotechnology lies in the seamless transition from research to regulated production. By integrating process development, CMC, and regulatory affairs from the very beginning, companies can avoid costly setbacks in late-stage development."
– Dr. Nils Sunder-Plassmann, Vice President of Pharmaceuticals, ENTOURAGE
Biotech consulting services: bioprocess development, CMC, and scale-up

Our biotech consulting services.

We combine in-depth biopharmaceutical expertise with operational excellence to provide comprehensive support to biotech companies.

Bioprocess Development & Scale-up
Development and optimization of upstream and downstream processes for monoclonal antibodies, recombinant proteins, and cell therapies. Scale-up from bench-top to commercial bioreactors, including process characterization and validation.
ATMP & Cell Therapy
Regulatory strategies for Advanced Therapy Medicinal Products (ATMPs), cell and gene therapies. Support with EMA/FDA approval, GMP compliance for autologous and allogeneic products, and facility design.
CMC & Analytical Development
CMC documentation for biologics and biosimilars, analytical method development and validation, stability programs, and comparability studies for process changes.
GMP & Inspection Readiness
GMP compliance for bioprocessing facilities, inspection readiness, and mock audits for the EMA and FDA. Contamination Control Strategies (CCS) for sterile and aseptic production.
Regulatory Affairs & Biosimilars
Regulatory strategies for biologics and biosimilars (EU, FDA, Swissmedic), biosimilar development programs, post-market surveillance, and scientific advice from the EMA and FDA.
Supply Chain & Cold Chain
GDP-compliant cold chain logistics for biologics and temperature-sensitive therapeutics, supplier qualification for raw materials and single-use components.

Our expertise in the biotech industry.

ENTOURAGE covers the entire biotech lifecycle through six specialized expertise clusters—from process development to commercial production.

Cluster 1

Regulatory & Compliance

Regulatory strategies (EMA, FDA, Swissmedic), post-market surveillance, variation management, and inspection readiness for pharmaceuticals.

GMP · Annex 1 · FDA · ATMPs · Health Authority Cluster 2

Quality Management

GMP-compliant quality management systems, CAPA and deviation management, process validation, cleanroom qualification, and continuous improvement.

CAPA · Deviations · ISO 9001 · GLP · Lean Six Sigma Cluster 3

Clinical and Medical Affairs

Clinical trials (Phases I–IV), GCP monitoring, pharmacovigilance, signal detection, CMC consulting, and QPPV services.

GCP · CRO · Pharmacovigilance · CMC · PMCF Cluster 4

R&D & Engineering

Feasibility studies, prototyping, design controls, verification and validation, and biocompatibility studies for pharmaceutical products.

V&V · Feasibility · Biocompatibility · Prototyping Cluster 5

Manufacturing & Supply Chain

CAPEX Consulting, Lean Manufacturing, Technology Transfer & Scale-up, GDP, Supplier Qualification, and Supply Chain Governance.

CAPEX · GDP · Lean · Scale-up · Procurement Cluster 6

Business Data Solutions & IT

Computer System Validation (CSV/GAMP 5), Data Integrity (ALCOA+), ERP Implementation, IT Audits, and Digital Governance.

CSV · ALCOA+ · Part 11 · ERP · ISO 27001

Why biotech companies work with ENTOURAGE.

What sets us apart from traditional management consultancies and individual consultants:

ENTOURAGE Major consulting projects Freelancer
Industry Focus 100% Life Sciences Across all industries A single niche
Implementation On-site operations More of a strategic move Hands-on, individual
Team size 200+ consultants, scalable Large teams available individual
Level of regulation GxP, FDA, EMA, ICH Generalist In a niche of its own
Flexibility Project contract or framework agreement Long contract terms Daily

Successful biotech projects.

Our case studies demonstrate how ENTOURAGE supports biotech companies with scale-up, regulatory approval, and GMP compliance.

Scale-up of a monoclonal antibody from a 2-liter to a 2,000-liter scale
Challenge: A biotech startup needed to scale up its lead candidate (monoclonal antibody) from laboratory scale to GMP-compliant commercial production within 12 months.

Measures: Process characterization and Design of Experiments (DoE), scale-up strategy with defined Critical Process Parameters (CPPs), process validation (PPQ) at the CDMO site.

Result: Successful scale-up with comparable product quality. PPQ batches within specifications. Submission of CMC data to the EMA on schedule.
ATMP Authorization for Autologous Cell Therapy
Challenge: A biotech company developed an autologous CAR-T cell therapy and required a regulatory strategy for EMA approval as an ATMP.

Actions: Regulatory classification, development of the GMP manufacturing strategy, establishment of the quality system for autologous production, Scientific Advice Meeting with the EMA.

Result: Positive feedback from the EMA during the Scientific Advice meeting. GMP manufacturing authorization granted. Phase III study launched as planned.
Biosimilar Development Program with a Comparability Strategy
Challenge: A mid-sized biotech company wanted to develop a biosimilar to a blockbuster antibody and required a comprehensive CMC and regulatory strategy.

Actions: Analytical comparability strategy, development of biosimilar-specific CMC documentation, regulatory submission strategy for the EU and FDA, coordination of the clinical PK study.

Result: Analytical similarity demonstrated. CMC dossier submitted. Development costs reduced by 30% through an optimized study strategy.

Frequently Asked Questions About Biotech Consulting.

What regulatory requirements for biologics does ENTOURAGE cover?
We cover the entire regulatory spectrum for biologics: EU GMP for bioprocessing, ATMP regulations (Regulation 1394/2007), ICH guidelines (Q5, Q6B, Q8–Q12), biosimilar-specific requirements, and FDA BLA submissions. Our experts have an average of 10+ years of experience with biologics.
Does ENTOURAGE support cell and gene therapies (ATMPs)?
Yes, ATMPs are one of our core areas of expertise. We provide support for the development and GMP manufacturing of CAR-T cell therapies, gene therapies, and tissue-engineered products—from facility design and process development through to EMA/FDA approval.
How does ENTOURAGE support the scale-up of biologics?
We support the entire scale-up process: process characterization, definition of CPPs and CQAs, Design of Experiments (DoE), technology transfer to a CDMO or to your own production facility, and process validation (PPQ). We place particular emphasis on ensuring consistent product quality across all scales.
What sets Entourage apart from traditional management consulting firms?
ENTOURAGE is not a traditional strategy consulting firm. Our consultants are trained scientists, engineers, and regulatory affairs experts who work directly on your projects—from the shop floor to regulatory submissions. We don’t just make recommendations; we put them into action.
Can ENTOURAGE provide support for biosimilar development?
Yes. We support biosimilar programs from the analytical similarity strategy through CMC development to regulatory submission to the EMA and FDA. Our experts assist with the planning of clinical PK/PD studies and the preparation of the biosimilar-specific dossier.
How does ENTOURAGE assist with CMC documentation for biologics?
Our CMC experts prepare and review Module 3 (Quality) for biologic drugs. This ranges from drug substance and drug product characterization to stability programs and comparability protocols for process changes. We are familiar with the specific expectations of the EMA and FDA regarding biologics dossiers.
What experience does ENTOURAGE have with CDMO management for biologics?
We have supported numerous CDMO selection and management projects for biotech companies. Our services range from supplier evaluation and contract negotiation to technology transfer, ongoing batch record review, and approval. Our experts manage the interface between the sponsor and the CDMO.

Your contacts for biotechnology.

Talk directly to our industry experts—we’ll connect you with the right team.

Dr. Nils sunder-plassmann
Dr. Nils Sunder-Plassmann
Vice President Pharma

Strategic consulting and project management for pharmaceutical clients in the areas of GMP, regulatory affairs, and supply chain.

Connect on LinkedIn
Andreas weirich
Andreas Weirich
Head of Pharma Sales

Your first point of contact for project inquiries, framework agreements, and customized consulting packages in the pharmaceutical sector.

Connect on LinkedIn

Other industries.

Industry

Pharmaceuticals

GMP consulting, Annex 1 compliance, inspection readiness, and supply chain consulting for pharmaceutical companies.

 Industry

Biotechnology

Scale-up of biologics, CMC consulting, GMP for ATMPs, and clinical development strategies.

 Industry

In Vitro Diagnostics (IVD)

IVDR Transition, Performance Studies, Performance Evaluation, and CE Marking for Diagnostics.

Your project begins with a conversation.

Describe your challenge—we’ll get back to you within 24 hours with a recommendation for the right expert.

Talk to our biotech experts.

Whether it's scale-up, ATMP approval, or CMC documentation—we'll find the right solution for your project.